Creatine Kinase MB Protein (CKM)
Quick Overview for Creatine Kinase MB Protein (CKM) (ABIN7849673)
Target
Protein Type
Origin
Source
Application
-
-
Purpose
- Native Human Creatine kinase MB,CK-MB protein
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCl pH 8.0, 5 mM beta Mercaptoethano and 6 % Sugrose.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Ship at 4°C.Upon receipt, aliquot and store at -20°C for long term. Avoid repeated freeze and thaw cycles.
-
-
- Creatine Kinase MB (CKM)
-
Alternative Name
- Creatine kinase MB
-
Background
-
Synonyms: CK-MB, B-CK, brain creatine kinase, CKBB, CKMB, CKMM, creatine kinase B, creatine kinase brain, creatine kinase M, Creatine kinase MB, Creatine Kinase MB type, creatine kinase muscle, M-CK, creatine kinase-M/B, KCRB_HUMAN, muscle creatine kinase
Description: Purified Creatine Kinase-MB Isoenzyme Protein.
Background: Creatine kinase isoenzyme-MB (CK-MB) is a biomarker for detecting myocardial injury. It is a simple, widely available, and useful biomarker for predicting adverse in-hospital clinical outcomes in pulmonary embolism. The encoded protein reversibly catalyzes the transfer of phosphate between ATP and various phosphogens such as creatine phosphate. It acts as a homodimer in striated muscle as well as in other tissues, and as a heterodimer with a similar brain isozyme in heart. The CK-MB-to-total-CK ratio is an easily available indicator and could be clinically utilized as a primary screening tool for cancer. Higher ratio of CK-MB-to-total-CK was specifically associated with certain malignancies, like colorectal cancer, lung cancer and hepatocellular carcinoma, as well as some cancer-associated status factors such as advanced stage and liver metastasis.
Target
-